Most biomarkers for the outcome of adenocarcinoma used in histology are related to the adenoma-carcinoma pathway and show mutations in oncogenes such as KRAS, NRAS, BRAF, APC, and DDF (41). This evidence concerns the gene NRAS and adenoma.